Millions of years of evolution has produced chemistry finely tuned to influence biology. This is the ideal starting point for therapies with the potential to reshape human health. We are harnessing the full potential of nature's uncharted chemistry to address the greatest medical challenges of our time.
60% of therapies developed in the last 30 years are derived from nature, yet only 5% of the natural world’s chemistry has been explored.
A platform purpose-built to enable and accelerate natural product drug discovery, leveraging AI and deep learning technologies to overcome longstanding historical limitations.
From screen to lead compound in six months–5x faster
4. Synthetic Biology
Rapidly scale for downstream R&D
3. Generative Design
Deep learning models to create better, optimized drug leads
2. Therapeutic Profiling
AI-powered screens for activity and mechanism in many diseases in parallel
1. Chemical Matter
Access never-before-seen natural chemistry
Our Source of Chemistry
A land of uninterrupted evolution
We are exploring untapped natural ecosystems to find the next generation of world-changing medicines hidden in wild fungi. Our first research site, Kapoose Creek, located on the northwest coast of Vancouver Island, was part of a rare ice-free corridor during the last ice age. As a result, this land has a rich ecosystem and unique mycological biodiversity.
A seasoned group of entrepreneurs, business leaders and scientists
Dr. Eric Brown
Chief Executive Officer
Chief Operating Officer
Dr. Geordie Stewart
Chief Business Development
Dr. Tomasz Czarny
VP Research and Development
Dr. Melissa Landon
VP Strategy and US Growth
Janet De Gouw
Research Lead, Biology
Dr. Michael Frankel
Chief Medical Advisor
The Board & Scientific Advisors
Founder and Chairman
Dr. Gerry Wright
General Manager, Jazz Pharmaceuticals
Dr. Leah Cowen
University of Toronto
CEO, Augurex Life Sciences
Dr. Max Cynader
University Of British Columbia
Dr. Armand Balboni
Director, Bloom Burton & Co Investment Bank
Dr. Matthew Miller
Dr. Andre Brown
Imperial College London
Want to get in touch? Reach out to the Kapoose Creek team.
Investor information available upon request.